Heterotypic Interactions of Amyloid β and the Islet Amyloid Polypeptide Produce Mixed Aggregates with Non-Native Fibril Structure. [PDF]
Baghel D, Ghosh A.
europepmc +1 more source
Human islet amyloid polypeptide: A therapeutic target for the management of type 2 diabetes mellitus. [PDF]
Roham PH, Save SN, Sharma S.
europepmc +1 more source
Author Correction: Targeting the IL-1β/IL-1Ra pathways for the aggregation of human islet amyloid polypeptide in an ex vivo organ culture system of the intervertebral disc. [PDF]
Wu X +8 more
europepmc +1 more source
Disaggregation of Islet Amyloid Polypeptide Fibrils as a Potential Anti-Fibrillation Mechanism of Tetrapeptide TNGQ. [PDF]
Abioye RO, Okagu OD, Udenigwe CC.
europepmc +1 more source
Inhibition of YIPF2 Improves the Vulnerability of Oligodendrocytes to Human Islet Amyloid Polypeptide. [PDF]
Zhang N +10 more
europepmc +1 more source
Understanding the structural dynamics of human islet amyloid polypeptide: Advancements in and applications of ion-mobility mass spectrometry. [PDF]
Dai Z +4 more
europepmc +1 more source
Flavones in pomelo peel resist fibril formation of human islet amyloid polypeptide. [PDF]
Gao C +7 more
europepmc +1 more source
Islet amyloid polypeptide fibril catalyzes amyloid-β aggregation by promoting fibril nucleation rather than direct axial growth. [PDF]
Song Z, Tang H, Gatch A, Sun Y, Ding F.
europepmc +1 more source
Human islet amyloid polypeptide-induced β-cell cytotoxicity is linked to formation of α-sheet structure. [PDF]
Hsu CC +7 more
europepmc +1 more source

